Risk of invasive cervical cancer among women with, or at risk for, HIV infection

International Journal of Cancer

Volumn 82, Issue 3, 1999, Pages 334-337

  Serraino, Diego ^a,b   Carrieri, Patrizia ^c   Pradier, Christian ^d   Bidoli, Ettore ^a   Dorrucci, Maria ^e   Ghetti, Elisa ^f   Schiesari, Antonella ^f   Zucconi, Roberta ^f   Pezzotti, Patrizio ^e   Dellamonica, Pierre ^d   Franceschi, Silvia ^a   Rezza, Giovanni ^e  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b IRCCS   (Italy)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f Centro Medico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; FEMALE; FRANCE; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; ITALY; MIDDLE AGED; NEOPLASM INVASIVENESS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0032971380     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990730)82:3<334::AID-IJC5>3.0.CO;2-C     Document Type: Article

References (20)

1. ALCABES, P., PEZZOTTI, P., PHILLIPS, A.N., REZZA, G. and VLAHOV, D., Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression. Amer. J. Epidemiol., 146, 543-551 (1997).
2. BASSETT, M.T., CHOKUNONGA, E., MAUCHAZA, B., LEVY, L., FERLAY, J. and PARKIN, D.M., Cancer in the African population of Harare, Zimbabwe, 1990-1992. Int. J. Cancer, 63, 29-36 (1995).
3. BRESLOW, N.E. and DAY, N.B., Statistical methods in cancer research. Volume II: The design and analysis of cohort studies, IARC Sci. Publ. 82, pp. 48-79, IARC, Lyon (1987).
4. CONTI, M., AGAROSSI, A., PARAZZINI, F., MUGOIASCA, M.L., BOSCHINI, A., NEGRI, E. and CASOLATI, E., HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers. Gynecol. Oncol., 49, 344-348 (1993).
5. EUROPEAN CENTRE FOR THE EPIDEMIOLOGICAL MONITORING OF AIDS, HIV/AIDS surveillance in Europe. Quart. Rep., 57 (1998).
6. FRANCESCHI, S., DAL MASO, L., ARNIANI, S., CROSIGNANI, P., VERCELLI, M., SIMONATO. L., FALCINI, E., ZANETTI, R., BARCHIELLI, A., SERRAINO, D. and REZZA, G., FOR THE CANCER AND AIDS REGISTRY LINKAGE STUDY, Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Brit. J. Cancer, 78, 966-970 (1998a).
7. FRANCESCHI, S., DAL MASO, L., SERRAINO, D., LO RE, A. and LA VECCHIA, C., Increasing incidence of AIDS among women. J. amer. Med. Ass., 279, 354-355 (1998b).
8. GOEDERT, J.J., COTÉ, T.R., VIRGO, P., SCOPPA, S.M., KINGMA, D.W., GAIL, M.H., JAFFE, E.S. and BIGGAR, R.J., FOR THE AIDS-CANCER MATCH STUDY GROUP, Spectrum of AIDS-associated malignant disorders. Lancet, 351, 1833-1839 (1998).
9. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, IARC Monograph on the Evaluation of carcinogenic risk to humans: human immunodeficiency viruses and human T-cell lymphotropic viruses. Vol. 67, pp. 103-114, IARC, Lyon (1996).
10. JOHNSTONE, F.D., MCGOOGAN, E., SMART, G.E., BRETTLE, R.P. and PRESCOTT, R.J., A population-based, controlled study of the relation between HIV infection and cervical neoplasia. Brit. J. Obstet. Gynaecol., 101, 986-991 (1994).
11. KORN, A.P. and LANDERS, D.V., Gynecologic disease in women infected with human immunodeficiency virus type I. Review. J. Acq. immun. Def. Syndr. hum. Retrovirol., 9, 361-370 (1995).
12. PARKIN, D.M., WHELAN, S.L., FERLAY, J., RAYMOND, L. and YOUNG, J., Cancer incidence in five continents, Vol. VII, IARC Sci. Publ. 143, IARC, Lyon (1997).
13. PRADIER, C., PUGLIESE, P., CAISSOTTI, C., WEHRLEN-MARTINI, S., HUYNHVAN, E., PUEYO, B. and DELLAMONICA, P., Dossier médical informatisé pour les patients atteints d'infection par le VIH (AIDS): l'expérience du Service des maladies infectieuses du CHU de Nice. Méd. Mal. Infect., 28, 291-295 (1998).
14. RABKIN, C.S., BIGGAR, R.J., BAPTISTE, M.S., ABE, T., KOHLER, B.A. and NASCA, P.C., Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Int. J. Cancer, 55, 208-212 (1993).
15. REZZA, G., GIULIANI, M., SERRAINO, D., BRANCA, M., BENEDETTO, A., GARBUGLIA, A., IPPOLITO, G. and FRANCESCHI, S., Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection. Epidemiol. Infect., 121, 173-177 (1998).
16. REZZA, G. and 12 OTHERS, The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters. AIDS, 3, 87-90 (1989).
17. SELIK, R.M. and RABKIN, C.S., Cancer death rates associated with human immunodeficiency virus infection in the United States. J. nat. Cancer Inst., 90, 1300-1302 (1998).
18. SERRAINO, D., NAPOLI, P.A., ZACCARELLI, M., ALLIEGRO, M.B., PEZZOTTI, P. and REZZA, G., High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS, 10, 1041-1052 (1996).
19. SERRAINO, D., PEZZOTTI, P., DORRUCCI, M., ALLIEGRO, MB., SINICCO, A. and REZZA, G., Cancer incidence in a cohort of human immunodeficiency virus seroconverters. Cancer, 79, 1004-1008 (1997).
20. ZANETTA, G., MANEO, A., COLOMBO, A., RAGUSA, A., GABRIELE, A., PLACA, F. and MANGIONI, C., HIV infection and invasive cervical carcinoma in an Italian population: the need for closer screening programmes in seropositive patients. AIDS, 9, 909-912 (1995).